|
Vaccine Detail
Autoimmune diabetes DNA vaccine pND2-GAD65-BAX encoding GAD and BAX |
Vaccine Information |
- Vaccine Name: Autoimmune diabetes DNA vaccine pND2-GAD65-BAX encoding GAD and BAX
- Target Pathogen: Diabetes
- Target Disease: Diabetes
- Vaccine Ontology ID: VO_0004405
- Type: DNA vaccine
- Status: Research
- Host Species as Laboratory Animal Model: Mouse
- BAX
gene engineering:
- Type: DNA vaccine construction
- Description: Vector pND2 expressed secreted BAX (Li et al., 2004).
- Detailed Gene Information: Click Here.
- GAD65
gene engineering:
- Type: DNA vaccine construction
- Description: Vector pND2 expressed secreted GAD (Li et al., 2004).
- Detailed Gene Information: Click Here.
- DNA vaccine plasmid:
- DNA vaccine plasmid name:
- DNA vaccine plasmid VO ID: VO_0000293
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Mouse Response
- Vaccine Immune Response Type: VO_0003057
- Efficacy: Data revealed that the only mice showing a significant decrease in diabetes onset were those receiving plasmid pND2-SGAD55-BAX (47% diabetic) compared to mice receiving plasmid pND2-GAD65 (93% diabetic), pND2-GAD65-BAX (87% diabetic), and untreated mice (93% diabetic). Insulitis scoring showed that the decrease in diabetes incidence observed with mice receiving plasmid pND2-SGAD55-BAX was associated with a significant decrease in islet inflammation when compared to untreated mice, and mice receiving either plasmid pND2, pND2-SRUC3, -GAD65-BAX, or -GAD65 (Li et al., 2004).
|
References |
Li et al., 2004: Li AF, Hough J, Henderson D, Escher A. Co-delivery of pro-apoptotic BAX with a DNA vaccine recruits dendritic cells and promotes efficacy of autoimmune diabetes prevention in mice. Vaccine. 2004; 22(13-14); 1751-1763. [PubMed: 15068859].
|
|